Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
44.30
+0.34 (0.77%)
Sep 4, 2026, 3:00 PM CST
SHA:688580 Revenue
Nanjing Vishee Medical Technology had revenue of 120.40M CNY in the quarter ending June 30, 2026, with 5.11% growth. This brings the company's revenue in the last twelve months to 478.71M, up 14.27% year-over-year. In the year 2025, Nanjing Vishee Medical Technology had annual revenue of 462.73M with 15.66% growth.
Revenue (ttm)
478.71M
Revenue Growth
+14.27%
P/S Ratio
8.86
Revenue / Employee
753.87K
Employees
635
Market Cap
4.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 462.73M | 62.67M | 15.66% |
| Dec 31, 2024 | 400.06M | -62.16M | -13.45% |
| Dec 31, 2023 | 462.22M | 140.60M | 43.72% |
| Dec 31, 2022 | 321.62M | -108.42M | -25.21% |
| Dec 31, 2021 | 430.04M | 51.68M | 13.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 6.47B |
| Wuhan Huakang Century Clean Technology | 2.47B |
| Shenzhen Lifotronic Technology | 1.13B |
| Getein Biotech | 1.09B |
| Guangdong Biolight Meditech | 1.09B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Guangdong Transtek Medical Electronics | 999.28M |
| Shanghai Aohua Photoelectricity Endoscope | 793.05M |